Epstein-Barr Detection in Oral Cancer

Status Completed

Clinical Trial Summary

The aim of this study is to analyze oral squamous cell carcinoma and healthy oral mucosa for the possible presence of Epstein-Barr virus (EBV).

Clinical Trial Description

Epstein-Barr virus has been implicated in a range of malignant neoplasms, including in some studies, in the aetiology of oral squamous cell carcinoma but the influence of EBV in oral cancer remains unclear. This study will examine the prevalence of EBV infection in oral cancer by means of nested polymerase chain reaction. ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01039272
Study type	Observational
Source	UPECLIN HC FM Botucatu Unesp
Contact
Status	Completed
Phase	N/A
Start date	March 2008
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Completed	`NCT00158678` - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC	Phase 3
Completed	`NCT00933387` - A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma	Phase 2
Enrolling by invitation	`NCT05030597` - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma	N/A
Completed	`NCT03682562` - Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Recruiting	`NCT03684707` - Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions	Phase 4
Recruiting	`NCT06130332` - Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)	Phase 2
Recruiting	`NCT04372914` - Prevention of Oral DNA Damage by Black Raspberries	N/A
Active, not recruiting	`NCT03529422` - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN	Phase 2
Recruiting	`NCT03686020` - Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
Not yet recruiting	`NCT06060288` - Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Withdrawn	`NCT00951470` - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema	N/A
Completed	`NCT00964977` - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.	Phase 3
Completed	`NCT01418118` - Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery	Phase 4
Active, not recruiting	`NCT00232960` - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC	N/A
Recruiting	`NCT05429099` - Mandibular Reconstruction Preplanning (ViPMR)	Phase 2/Phase 3
Completed	`NCT04614896` - Use of Ultrasound for Measuring Size of Oral Tongue Cancers	N/A
Recruiting	`NCT03685409` - Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions	Phase 3
Completed	`NCT00402779` - Erlotinib Prevention of Oral Cancer (EPOC)	Phase 3
Recruiting	`NCT05153733` - Improved Implant for Reconstruction Purposes After Mandibular Resection	N/A